NERV Minerva Neurosciences, Inc - Common Stock
NASDAQ · Biotechnology · View on SEC EDGAR ↗ close Oct 2, 2026 10-K/10-Q Aug 7, 2026
$3.28
· of 52w range
· above low
· to high
$2.0852w low
$12.4652w high
Market Cap (MRQ)
$155M
P/E
-0.1
EPS
$-34.67
Revenue
$0
your badges
52W Range
$2–$12
Analyst Rating
BUY
Price Target
$10
P/E
-0.1
ROE
339.5%
Net Profit Margin
·
Your badge strip is empty — pin a metric anywhere on this page.
NERV Stock Snapshot Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range
Price
$3.28
Market Cap (MRQ)
$155M
P/E
-0.1
EPS
$-34.67
Revenue
$0
ROE
339.5%
52W Range
$2–$12
NERV Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view
range
bars
Bar granularity adapts to the selected period — hover the chart to see open/high/low/close for a bar.
Stock splits
| Ex-date | Split | Type |
|---|---|---|
| June 21, 2022 | 1-for-8 | Reverse |
About Minerva Neurosciences, Inc - Common Stock Company overview from Wikipedia
sectorHealthcare
industryBiotechnology
employees7
countryUS
10-Year Performance Revenue, net income, margins and EPS trends
Revenue$02017-12-31 → 2024-12-31
EPS$-34.672019-12-31 → 2025-12-31
Free Cash Flow·2017-12-31 → 2017-12-31
Net margin·2020-12-31 → 2020-12-31
Valuation & Ratios
Valuation P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?
| Metric | 5Y trend | NERV | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| P/E | -0.15Y avg ≈1.9 | ≈1.9 | · | · | |
| P/B (MRQ) | -0.7 | · | · | · | |
| Price / Cash Flow | -10.6 | · | · | · |
Peer median is calculated on a standardized basis per metric and may not always match the TTM/MRQ basis shown for this stock.
Profitability Gross, operating and net margins; ROE, ROA, ROIC
| Metric | 5Y trend | NERV | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| ROA | -434.3% | · | -56.4% | Weak | |
| ROE | 339.5% | · | -60.0% | Top tier |
Financial Health Debt, liquidity, solvency — balance sheet strength
| Metric | 5Y trend | NERV | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Current Ratio (MRQ) | 20.1 | · | 9.2 | Strong liquidity | |
| Quick Ratio | 35.9 | · | 7.8 | Strong liquidity |
Growth Revenue, EPS and net income growth: YoY, 3Y CAGR, 5Y CAGR
No data for this ratio group yet
Not enough fundamentals data to compute this ratio group yet.
Capital Efficiency Asset turnover, inventory turnover, receivables turnover
| Metric | 5Y trend | NERV | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Revenue / Employee | ≈$0.00 | · | · | · |
value · ≈ 5Y avg · industry median · verdict relative to median
Earnings History EPS actual vs estimate, surprise %, beat rate, next earnings date
Avg Surprise
-5.1%
Next Report
Nov 03, 2026
| Period | Report | EPS Actual | EPS Est | Surprise |
|---|---|---|---|---|
| June 30, 2026 | Aug 12, 2026 | $-0.17 | $-0.12 | -44.9% |
| March 31, 2026 | May 11, 2026 | $-0.17 | $-0.13 | -31.6% |
| Dec. 31, 2025 | $-0.64 | $-0.31 | -109.2% | |
| June 30, 2025 | $-0.43 | $-0.92 | 53.2% | |
| March 31, 2025 | $-0.50 | $-1.09 | 54.2% | |
| Dec. 31, 2024 | $-0.56 | $-1.07 | 47.7% |
Full Fundamentals All metrics by year — income statement, balance sheet, cash flow
Income Statement
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | · | $0 | $0 | $0 | · | $41M | $0 | $0 | $0 | |
| R&D Expense | $6M | $12M | $13M | $15M | $32M | $22M | $58M | $35M | $30M | |
| SG&A Expense | $9M | $10M | $10M | $11M | $13M | $17M | $18M | $17M | $11M | |
| Operating Expenses | $15M | $22M | $23M | $25M | $45M | $39M | $76M | $52M | $41M | |
| Operating Income | $-15M | $-22M | $-23M | $-25M | $-45M | $2M | $-76M | $-52M | $-41M | |
| Interest Income | $948.1K | $1M | $1M | $556.9K | $16.5K | $161.2K | $1M | $2M | $941.8K | |
| Pretax Income | · | · | · | $-32M | $-52M | $2M | $-74M | $-50M | $-41M | |
| Income Tax | · | · | · | · | $-2M | · | $-2M | $0 | $-9M | |
| Net Income | $-293M | $1M | $-30M | $-32M | $-50M | $2M | $-72M | $-50M | $-32M | |
| EPS (Basic) | $-34.67 | $0.19 | $-4.61 | $-6.01 | $-9.35 | $0.05 | $-1.85 | · | · | |
| EPS (Diluted) | $-34.67 | $0.19 | $-4.61 | $-6.01 | $-9.35 | $0.05 | $-1.85 | · | · | |
| Shares (Basic) | 8,463,581 | 7,568,981 | 6,506,372 | 5,340,194 | 5,340,196 | 40,823,717 | 39,014,302 | · | · | |
| Shares (Diluted) | 8,463,581 | 7,573,763 | 6,506,372 | 5,340,194 | 5,340,196 | 40,916,871 | 39,014,302 | · | · | |
| EBITDA | $-15M | · | · | · | $-45M | $2M | $-76M | $-52M | $-41M |
Balance Sheet
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $82M | $21M | $41M | $36M | $61M | $25M | $21M | $50M | $26M | |
| Short-term Investments | · | · | · | · | · | · | $24M | $38M | $102M | |
| Prepaid Expense | $697.7K | $806.9K | $989.9K | $848.1K | $1M | $2M | $1M | $2M | $1M | |
| Current Assets | $83M | $22M | $42M | $40M | $62M | $27M | $47M | $90M | $130M | |
| PP&E (Net) | $0 | $5.4K | $10.9K | $16.3K | · | · | $16.0K | $33.5K | $50.9K | |
| Goodwill | $15M | $15M | $15M | $15M | $15M | $15M | $15M | $15M | $15M | |
| Intangibles | · | · | · | · | · | $15M | $15M | $34M | $34M | |
| Other Non-current Assets | · | · | · | · | · | $14.8K | $14.8K | $14.8K | $14.8K | |
| Total Assets | $98M | $37M | $57M | $55M | $77M | $58M | $77M | $139M | $184M | |
| Accounts Payable | $639.7K | $2M | $2M | $969.7K | $2M | $995.6K | $2M | $2M | $1M | |
| Short-term Debt | · | · | · | · | · | · | · | · | $4M | |
| Current Liabilities | $2M | $3M | $3M | $1M | $3M | $3M | $7M | $4M | $7M | |
| Capital Leases | · | · | · | · | · | · | $111.2K | · | · | |
| Deferred Tax | · | · | · | · | · | $2M | $2M | $4M | $4M | |
| Other Non-current Liabilities | · | · | · | · | · | · | · | $29.0K | $29.9K | |
| Total Liabilities | $234M | $63M | $85M | $75M | $69M | $5M | $50M | $49M | $52M | |
| Total Debt | · | · | · | · | · | · | · | · | $4M | |
| Common Stock | $4.3K | $699 | $699 | $534 | $534 | $4.3K | $3.9K | $3.9K | $3.9K | |
| Retained Earnings | $-689M | $-395M | $-397M | $-367M | $-335M | $-285M | $-287M | $-215M | $-164M | |
| Stockholders' Equity | $-141M | $-26M | $-28M | $-20M | $8M | $53M | $28M | $90M | $132M | |
| Liabilities + Equity | $98M | $37M | $57M | $55M | $77M | $58M | $77M | $139M | $184M | |
| Shares Outstanding | 43,274,398 | 6,993,406 | 6,993,406 | 5,340,193 | 5,340,196 | 5,340,196 | 39,084,121 | 38,937,971 | 38,749,343 |
Cash Flow
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $5.4K | $5.4K | $5.4K | · | · | $16.0K | $17.5K | $17.5K | $11.1K | |
| Stock-based Comp | $1M | $1M | $2M | $4M | $5M | $10M | $9M | $8M | $5M | |
| Other Non-cash | · | · | · | · | · | $-45M | $20M | $29.4K | $30M | |
| Operating Cash Flow | $-14M | $-20M | $-15M | $-25M | $-25M | $-34M | $-43M | $-42M | $3M | |
| CapEx | · | · | · | $16.3K | · | · | · | · | $52.4K | |
| Investing Cash Flow | $0 | $0 | $0 | $-16.3K | · | $25M | $14M | $69M | $-107M | |
| Stock Repurchased | · | · | · | · | · | · | · | · | $389 | |
| Net Stock Activity | · | · | · | · | · | · | · | · | $-389 | |
| Financing Cash Flow | $74M | · | $20M | $-5 | $60M | $13M | $525.0K | $-3M | $47M | |
| Net Change in Cash | $61M | $-20M | $5M | $-25M | $35M | $4M | $-29M | $24M | $-57M | |
| Taxes Paid | $0 | $0 | · | · | · | · | · | · | · | |
| Free Cash Flow | · | · | · | · | · | · | · | · | $3M |
Profitability
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | · | · | · | · | · | 4.5% | · | · | · | |
| Net Margin | · | · | · | · | · | 4.7% | · | · | · | |
| Pretax Margin | · | · | · | · | · | 4.7% | · | · | · | |
| EBITDA Margin | · | · | · | · | · | 4.5% | · | · | · | |
| ROA | -434.3% | · | · | · | -74.1% | 2.9% | -66.6% | -31.1% | -19.9% | |
| ROE | 339.5% | · | · | · | -276.8% | 3.5% | -173.3% | -52.3% | -24.1% | |
| ROIC | · | · | · | · | -549.0% | · | -264.8% | -57.3% | -23.4% |
Liquidity & Solvency
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 36.3 | · | · | · | 22.1 | 8.7 | 7.1 | 24.9 | 18.9 | |
| Quick Ratio | 35.9 | · | · | · | 21.6 | 8.0 | 6.9 | 24.4 | 18.7 | |
| Debt / Equity | · | · | · | · | · | · | · | · | 0.0 |
Efficiency
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | · | · | · | · | · | 0.6 | 0.0 | 0.0 | 0.0 |
Per Share
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $-3.25 | · | · | · | $0.19 | $1.23 | $0.71 | $2.32 | $3.40 | |
| Revenue / Share | · | · | · | · | · | $1.01 | · | · | · | |
| Cash Flow / Share | $-1.60 | · | · | · | $-0.58 | $-0.83 | · | · | · | |
| Cash / Share | $1.90 | · | · | · | $1.42 | $0.59 | $0.55 | $1.29 | $0.67 | |
| EPS (TTM) | $-34.67 | $0.19 | $-4.61 | $-6.01 | $-9.35 | $0.05 | $-1.85 | · | · |
Valuation (TTM)
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | · | $0 | $0 | $0 | · | $41M | $0 | $0 | $0 | |
| Net Income TTM | $-293M | $1M | $-30M | $-32M | $-50M | $2M | $-72M | $-50M | $-32M | |
| Market Cap | $174M | · | · | · | $274M | $800M | $2.22B | $2.10B | $1.88B | |
| Enterprise Value | · | · | · | · | · | · | · | · | $1.75B | |
| P/E | -0.1 | 11.7 | -1.3 | -0.3 | -0.7 | 374.4 | -30.7 | · | · | |
| P/S | · | · | · | · | · | 19.4 | · | · | · | |
| P/B | -1.2 | · | · | · | 34.3 | 15.2 | 80.0 | 23.3 | 14.3 | |
| P / Tangible Book | · | · | · | · | · | 35.4 | · | · | · | |
| P / Cash Flow | -12.9 | · | · | · | -11.1 | -23.6 | -51.2 | -50.1 | 606.4 | |
| P / FCF | · | · | · | · | · | · | · | · | 616.8 | |
| EV / EBITDA | · | · | · | · | · | · | · | · | -42.5 | |
| EV / FCF | · | · | · | · | · | · | · | · | 576.0 | |
| Earnings Yield | -862.4% | 8.6% | -75.0% | -378.0% | -145.9% | 0.27% | -3.2% | · | · |
Income Statement
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| R&D Expense | $7M | $5M | $2M | $925.4K | $1M | $1M | $2M | $2M | $4M | $4M | $5M | $3M | $2M | $3M | $3M | $2M | |
| SG&A Expense | $3M | $11M | $3M | $2M | $2M | $3M | $3M | $2M | $2M | $3M | $2M | $3M | $3M | $3M | $2M | $3M | |
| Operating Expenses | $11M | $17M | $5M | $3M | $3M | $4M | $5M | $4M | $6M | $7M | $7M | $6M | $5M | $5M | $5M | $5M | |
| Operating Income | $-11M | $-17M | $-5M | $-3M | $-3M | $-4M | $-5M | $-4M | $-6M | $-7M | $-7M | $-6M | $-5M | $-5M | $-5M | $-5M | |
| Interest Income | $569.6K | $629.6K | $546.5K | $106.6K | $136.7K | $158.3K | $239.7K | $314.0K | $360.8K | $357.9K | $358.9K | $348.7K | $365.6K | $364.2K | $297.1K | $180.1K | |
| Net Income | $17M | $-125M | $-284M | $-3M | $-3M | $-4M | $-4M | $23M | $-8M | $-9M | $-9M | $-8M | $-6M | $-7M | $-7M | $-7M | |
| EPS (Basic) | $0.36 | $-2.86 | $-33.38 | $-0.36 | $-0.43 | $-0.50 | $-0.56 | $2.97 | $-1.09 | $-1.13 | $-1.15 | $-1.03 | $-1.12 | $-1.31 | $-1.26 | $-1.29 | |
| EPS (Diluted) | $-0.14 | $-2.86 | $-33.38 | $-0.36 | $-0.43 | $-0.50 | $-0.56 | $2.97 | $-1.09 | $-1.13 | $-1.15 | $-1.03 | $-1.12 | $-1.31 | $-1.26 | $-1.29 | |
| Shares (Basic) | 46,599,044 | 43,900,426 | · | 7,568,981 | 7,568,981 | 7,568,981 | · | 7,568,981 | 7,568,981 | 7,568,981 | · | 7,568,981 | 5,511,163 | 5,340,193 | · | 5,340,193 | |
| Shares (Diluted) | 79,104,585 | 43,900,426 | · | 7,568,981 | 7,568,981 | 7,568,981 | · | 7,568,981 | 7,568,981 | 7,568,981 | · | 7,568,981 | 5,511,163 | 5,340,193 | · | 5,340,193 | |
| EBITDA | $-11M | $-17M | · | $-3M | $-3M | $-4M | · | $-4M | $-6M | $-7M | · | $-6M | $-5M | $-5M | · | $-5M |
Balance Sheet
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $25M | $33M | $82M | $12M | $15M | $17M | $21M | $27M | $31M | $35M | $41M | $47M | $52M | $36M | $36M | $40M | |
| Short-term Investments | $51M | $45M | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Prepaid Expense | $4M | $941.9K | $697.7K | $633.5K | $199.6K | $534.8K | $806.9K | $1M | $428.0K | $702.5K | $989.9K | $1M | $329.2K | $596.0K | $848.1K | $1M | |
| Current Assets | $80M | $79M | $83M | $13M | $16M | $18M | $22M | $28M | $31M | $36M | $42M | $48M | $52M | $37M | $40M | $45M | |
| PP&E (Net) | · | · | $0 | $1.4K | $2.7K | $4.1K | $5.4K | $6.8K | $8.2K | $9.5K | $10.9K | $12.2K | $13.6K | $15.0K | $16.3K | · | |
| Goodwill | $15M | $15M | $15M | $15M | $15M | $15M | $15M | $15M | $15M | $15M | $15M | $15M | $15M | $15M | $15M | $15M | |
| Total Assets | $95M | $94M | $98M | $28M | $30M | $33M | $37M | $43M | $46M | $51M | $57M | $63M | $67M | $52M | $55M | $60M | |
| Accounts Payable | $1M | $2M | $639.7K | $944.5K | $896.8K | $639.9K | $2M | $553.2K | $828.3K | $1M | $2M | $1M | $298.3K | $961.0K | $969.7K | $532.9K | |
| Current Liabilities | $4M | $4M | $2M | $3M | $3M | $2M | $3M | $4M | $4M | $3M | $3M | $3M | $2M | $3M | $1M | $2M | |
| Total Liabilities | $297M | $343M | $234M | $63M | $63M | $62M | $63M | $64M | $91M | $87M | $85M | $83M | $80M | $78M | $75M | $74M | |
| Common Stock | $4.7K | $4.4K | $4.3K | $699 | $699 | $699 | $699 | $699 | $699 | $699 | $699 | $699 | $699 | $534 | $534 | $534 | |
| Retained Earnings | $-797M | $-814M | $-689M | $-405M | $-402M | $-399M | $-395M | $-391M | $-414M | $-405M | $-397M | $-388M | $-380M | $-374M | $-367M | $-360M | |
| Stockholders' Equity | $-213M | $-254M | $-141M | $-35M | $-32M | $-29M | $-26M | $-22M | $-44M | $-37M | $-28M | $-20M | $-13M | $-27M | $-20M | $-14M | |
| Liabilities + Equity | $95M | $94M | $98M | $28M | $30M | $33M | $37M | $43M | $46M | $51M | $57M | $63M | $67M | $52M | $55M | $60M | |
| Shares Outstanding | 47,227,259 | 43,841,998 | 43,274,398 | 6,993,406 | 6,993,406 | 6,993,406 | 6,993,406 | 6,993,406 | 6,993,406 | 6,993,406 | 6,993,406 | 6,993,406 | 6,993,406 | 5,340,193 | 5,340,193 | 5,340,193 |
Cash Flow
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | · | · | $1.4K | $1.4K | $1.4K | $1.4K | $1.4K | $1.4K | $1.4K | $1.4K | $1.4K | $1.4K | $1.4K | $1.4K | · | · | |
| Stock-based Comp | $2M | $9M | $459.0K | $272.9K | $298.2K | $297.2K | $249.7K | $307.7K | $329.3K | $438.8K | $611.1K | $371.9K | $608.9K | $376.5K | $947.7K | $1M | |
| Operating Cash Flow | $-13M | $-5M | $-4M | $-3M | $-2M | $-4M | $-5M | $-4M | $-4M | $-6M | $-6M | $-5M | $-4M | $-115.4K | $-4M | $-10M | |
| Investing Cash Flow | $-5M | $-45M | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $-16.3K | · | |
| Financing Cash Flow | $10M | $1M | $74M | $-45.2K | $0 | $0 | · | · | $0 | $0 | $0 | $-86.7K | $20M | $0 | $0 | $0 | |
| Net Change in Cash | $-8M | $-50M | $70M | $-3M | $-2M | $-4M | $-5M | $-4M | $-4M | $-6M | $-6M | $-5M | $16M | $-115.4K | $-4M | $-10M |
Profitability
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROA | 27.8% | -197.8% | · | -7.7% | -8.5% | -9.0% | · | 42.5% | -14.5% | -16.8% | · | -12.7% | -9.4% | -11.4% | · | -8.8% | |
| ROE | -14.2% | 88.6% | · | 9.8% | 8.5% | 11.4% | · | -107.9% | 28.9% | 27.1% | · | 45.6% | 59.3% | 51.0% | · | -99.8% |
Liquidity & Solvency
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 20.1 | 17.6 | · | 4.9 | 6.1 | 9.2 | · | 6.2 | 7.5 | 12.6 | · | 14.4 | 27.4 | 14.7 | · | 20.4 | |
| Quick Ratio | 19.0 | 17.4 | · | 4.6 | 6.0 | 8.9 | · | 5.9 | 7.3 | 12.3 | · | 14.0 | 27.1 | 14.4 | · | 18.3 |
Per Share
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $-4.52 | $-5.79 | · | $-4.94 | $-4.59 | $-4.17 | · | $-3.10 | $-6.36 | $-5.23 | · | $-2.87 | $-1.79 | $-4.98 | · | $-2.67 | |
| Cash Flow / Share | · | $-0.12 | · | · | · | $-0.54 | · | · | · | $-0.81 | · | · | · | $-0.02 | · | · | |
| Cash / Share | $0.52 | $0.74 | · | $1.76 | $2.18 | $2.47 | · | $3.79 | $4.42 | $4.98 | · | $6.71 | $7.41 | $6.74 | · | $7.53 | |
| EPS (TTM) | $-36.74 | $-37.03 | · | $-1.85 | $1.48 | $0.82 | · | $-0.40 | $-4.40 | $-4.43 | · | $-4.72 | $-4.98 | $-5.49 | · | $-8.74 |
Valuation (TTM)
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $41M | $41M | · | $41M | $41M | $41M | · | $41M | $41M | $41M | · | $41M | $41M | $41M | · | $41M | |
| Net Income TTM | $-394M | $-415M | · | $-14M | $11M | $6M | · | $-3M | $-34M | $-32M | · | $-28M | $-27M | $-29M | · | $-47M | |
| Market Cap | $262M | $264M | · | $15M | $12M | $12M | · | $19M | $22M | $18M | · | $48M | $64M | $9M | · | $49M | |
| P/E | -0.2 | -0.2 | · | -1.1 | 1.2 | 2.1 | · | -6.7 | -0.7 | -0.6 | · | -1.5 | -1.8 | -0.3 | · | -1.1 | |
| P/S | 6.4 | 6.4 | · | 0.4 | 0.3 | 0.3 | · | 0.5 | 0.5 | 0.4 | · | 1.2 | 1.6 | 0.2 | · | 1.2 | |
| P/B | -1.2 | -1.0 | · | -0.4 | -0.4 | -0.4 | · | -0.9 | -0.5 | -0.5 | · | -2.4 | -5.1 | -0.3 | · | -3.5 | |
| P / Cash Flow | · | -48.7 | · | · | · | -2.9 | · | · | · | -3.0 | · | · | · | -74.0 | · | · | |
| Earnings Yield | -662.0% | -614.6% | · | -87.9% | 86.1% | 48.2% | · | -15.0% | -137.9% | -171.7% | · | -68.4% | -54.5% | -343.1% | · | -94.7% |
Most recent period on the left · null values shown as ·
Financial Statements Income statement, balance sheet, cash flow — annual, last 5 years
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Revenue | · | $0 | $0 | $0 | · |
| Net Income | $-293M | $1M | $-30M | $-32M | $-50M |
| Diluted EPS | $-34.67 | $0.19 | $-4.61 | $-6.01 | $-9.35 |
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Current Ratio | 36.3 | · | · | · | 22.1 |
| Quick Ratio | 35.9 | · | · | · | 21.6 |
No data for this statement
Not enough fundamentals data to build this statement yet.
Institutional owners (13F) 60 filers · $237.2M total · As of June 30, 2026
Institutions that report holding this stock in their quarterly SEC Form 13F. Long positions only; a single filer may appear twice for separate option legs. Large offsetting put/call legs typically reflect market-making or hedged inventory, not directional conviction.
Holders
60
Value held
$237.2M
New positions
24
Exited positions
8
Institutional activity — Q2 2026 vs prior quarter
| New positions | Exited positions | Increased | Decreased | Net shares change |
|---|---|---|---|---|
| 24 (+6 vs prior Q) | 8 (+5 vs prior Q) | 15 (+7 vs prior Q) | 9 (+1 vs prior Q) | +2.0M |
Compared to Q1 2026. SEC Form 13F filings are due within 45 days of quarter-end plus a short buffer for late filers — quarters still inside that window are skipped in favor of the most recent fully-reported pair.
| Institution | Value | Shares | % of tracked 13F | Type |
|---|---|---|---|---|
| FEDERATED HERMES, INC. | $25,920,864 | 4,670,426 | 10.93% | Shares |
| JANUS HENDERSON GROUP PLC | $25,872,910 | 4,294,259 | 10.91% | Shares |
| Vivo Capital, LLC | $23,991,246 | 4,322,747 | 10.11% | Shares |
| Balyasny Asset Management L.P. | $23,626,350 | 4,257,000 | 9.96% | Shares |
| Logos Global Management LP | $18,252,712 | 3,288,777 | 7.69% | Shares |
| FARALLON CAPITAL MANAGEMENT, L.L.C. | $13,125,750 | 2,365,000 | 5.53% | Shares |
| BlackRock, Inc. | $12,435,208 | 2,240,578 | 5.24% | Shares |
| Ally Bridge Group (NY) LLC | $12,075,701 | 2,175,802 | 5.09% | Shares |
| Foresite Capital Management VI LLC | $11,019,991 | 1,985,584 | 4.65% | Shares |
| VANGUARD CAPITAL MANAGEMENT LLC | $10,505,079 | 1,892,807 | 4.43% | Shares |
| Spruce Street Capital LP | $9,188,025 | 1,655,500 | 3.87% | Shares |
| Trails Edge Capital Partners, LP | $7,875,450 | 1,419,000 | 3.32% | Shares |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | $7,875,450 | 1,419,000 | 3.32% | Shares |
| Seven Fleet Capital Management LP | $5,557,620 | 1,001,373 | 2.34% | Shares |
| GEODE CAPITAL MANAGEMENT, LLC | $5,408,947 | 974,236 | 2.28% | Shares |
| DV EQUITIES, LLC | $4,186,903 | 754,397 | 1.76% | Shares |
| ACUTA CAPITAL PARTNERS, LLC | $3,937,725 | 709,500 | 1.66% | Shares |
| MILLENNIUM MANAGEMENT LLC | $2,961,491 | 533,602 | 1.25% | Shares |
| STATE STREET CORP | $2,358,278 | 424,915 | 0.99% | Shares |
| VANGUARD FIDUCIARY TRUST CO | $1,679,452 | 302,604 | 0.71% | Shares |
| NORTHERN TRUST CORP | $1,621,249 | 292,117 | 0.68% | Shares |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $1,302,885 | 234,754 | 0.55% | Shares |
| VANGUARD GROUP INC | $1,013,156 | 252,029 | 0.43% | Shares |
| GOLDMAN SACHS GROUP INC | $798,945 | 143,954 | 0.34% | Shares |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $630,619 | 113,625 | 0.27% | Shares |
| Bank of New York Mellon Corp | $419,468 | 75,580 | 0.18% | Shares |
| RENAISSANCE TECHNOLOGIES LLC | $406,815 | 73,300 | 0.17% | Shares |
| Y-Intercept (Hong Kong) Ltd | $359,013 | 64,687 | 0.15% | Shares |
| Walleye Capital LLC | $299,128 | 53,897 | 0.13% | Shares |
| Nuveen, LLC | $252,403 | 45,478 | 0.11% | Shares |
| UBS Group AG | $234,254 | 42,208 | 0.10% | Shares |
| Invesco Ltd. | $220,274 | 39,689 | 0.09% | Shares |
| BANK OF AMERICA CORP /DE/ | $209,413 | 37,732 | 0.09% | Shares |
| Apella Capital, LLC | $201,533 | 42,250 | 0.08% | Shares |
| DEUTSCHE BANK AG\ | $184,687 | 33,277 | 0.08% | Shares |
| WELLS FARGO & COMPANY/MN | $167,993 | 30,269 | 0.07% | Shares |
| RHUMBLINE ADVISERS | $165,755 | 29,867 | 0.07% | Shares |
| TWO SIGMA INVESTMENTS, LP | $142,496 | 25,675 | 0.06% | Shares |
| NEW YORK STATE COMMON RETIREMENT FUND | $109,890 | 19,800 | 0.05% | Shares |
| CITIGROUP INC | $88,650 | 15,973 | 0.04% | Shares |
| MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. | $87,013 | 15,678 | 0.04% | Shares |
| Vanguard Global Advisers, LLC | $85,109 | 15,335 | 0.04% | Shares |
| JPMORGAN CHASE & CO | $76,644 | 14,115 | 0.03% | Shares |
| MORGAN STANLEY | $69,058 | 12,443 | 0.03% | Shares |
| Police & Firemen's Retirement System of New Jersey | $57,420 | 10,346 | 0.02% | Shares |
| BNP PARIBAS FINANCIAL MARKETS | $43,806 | 7,893 | 0.02% | Shares |
| BARCLAYS PLC | $37,884 | 6,826 | 0.02% | Shares |
| Tower Research Capital LLC (TRC) | $20,407 | 3,677 | 0.01% | Shares |
| Legal & General Group Plc | $18,426 | 3,320 | 0.01% | Shares |
| Ameritas Investment Partners, Inc. | $17,150 | 3,090 | 0.01% | Shares |
Activists & 5%+ owners 5 positions
Investors who filed SEC Schedule 13D — beneficial ownership above 5% with an intent to influence the issuer (activist stakes, board campaigns, M&A). Each row shows the most recent known state of that filer's position.
| Filer | Filed | Stake | Status | Purpose | Filing |
|---|---|---|---|---|---|
| Boehringer AG, Boehringer Ingelheim International GmbH ×2 filings | Dec. 30, 2025 | 3.40% | Amendment | · | SEC |
| INDEX VENTURE ASSOCIATES III LIMITED, INDEX VENTURES III (JERSEY) L.P., INDEX VENTURES III (DELAWARE) L.P., INDEX VENTURES III PARALLEL ENTREPRENEUR FUND (JERSEY) L.P., INDEX VENTURE ASSOCIATES IV LIMITED, INDEX VENTURES IV (JERSEY) L.P., INDEX VENTURES IV PARALLEL ENTREPRENEUR FUND (JERSEY) L.P., INDEX VENTURE ASSOCIATES V LIMITED, INDEX VENTURES V (JERSEY) L.P., INDEX VENTURES V PARALLEL ENTREPRENEUR FUND (JERSEY) L.P., YUCCA (JERSEY) SLP ×5 filings | June 18, 2019 | · | Initial filing | Passive investment | SEC |
| Care Capital Investments III L.P., Care Capital Offshore Investments III LP, Care Capital III LLC ×5 filings | May 5, 2016 | · | Initial filing | · | SEC |
| Care Capital III LLC, Care Capital Investments III LP, Care Capital Offshore Investments III LP | July 18, 2014 | · | Initial filing | Passive investment | SEC |
| Remy Luthringer, Wint2felden Holding SA | July 17, 2014 | · | Initial filing | Passive investment | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Company insiders 24 insiders · 10 officers · 14 directors
| Insider | Role | Last activity | Shares owned | Buys 12m | Sells 12m | Net 12m |
|---|---|---|---|---|---|---|
| Remy Luthringer | CEO | June 3, 2026 A | 68,994 | 0 | 0 | $0 |
| Coelho Rogerio Vivaldi | President and CEO | June 30, 2014 A | 41,667 | 0 | 0 | $0 |
| Frederick W Ahlholm | SVP, CFO and Secretary | June 3, 2026 A | 17,518 | 0 | 0 | $0 |
| Geoff Race | President | Dec. 22, 2025 A | 51,324 | 0 | 0 | $0 |
| Richard E. Russell | President | June 19, 2020 A | 33,770 | 0 | 0 | $0 |
| Joseph H. Reilly | SVP & Chief Operating Officer | Dec. 14, 2020 M | 31,747 | 0 | 0 | $0 |
| James Joseph O'Connor | Chief Business Officer and GC | April 21, 2026 A | · | 0 | 0 | $0 |
| Devin Whittemore Smith | SVP and General Counsel | Oct. 13, 2020 A | · | 0 | 0 | $0 |
| Jay Saoud | SVP and Head of R&D | Oct. 13, 2020 A | · | 0 | 0 | $0 |
| Mark S. Levine | SVP,General Counsel & Sec. | June 1, 2017 M | 0 | 0 | 0 | $0 |
| Inderjit Kaul | Director | Aug. 3, 2026 A | · | 0 | 0 | $0 |
| David Kupfer | Director | June 3, 2026 A | 163,553 | 0 | 0 | $0 |
| Fouzia Laghrissi-Thode | Director | June 3, 2026 A | · | 0 | 0 | $0 |
| HASLER HANS PETER | Director | June 3, 2026 A | 10,000 | 0 | 0 | $0 |
| VAN HEEK G JAN | Director | June 3, 2026 A | 20,333 | 0 | 0 | $0 |
| Jeryl L Hilleman | Director | Sept. 27, 2023 A | 1,000 | 0 | 0 | $0 |
| William F Doyle | Director | June 10, 2022 A | 26,111 | 0 | 0 | $0 |
| Marc D Beer | Director | Jan. 31, 2018 A | 50,000 | 0 | 0 | $0 |
| Nico Vandervelpen | Director | July 24, 2017 A | · | 0 | 0 | $0 |
| De Rubertis Francesco | Director | Dec. 12, 2016 X | 4,690,906 | 0 | 0 | $0 |
| Michele Ollier | Director | Dec. 12, 2016 X | 4,690,906 | 0 | 0 | $0 |
| Lorenzo Pellegrini | Director | July 7, 2014 C | 3,883,212 | 0 | 0 | $0 |
| BARCLAYS PLC | 10% owner | Aug. 11, 2022 | · | 0 | 0 | $0 |
| Michael Davidson | · | Oct. 13, 2020 A | · | 0 | 0 | $0 |
Insiders from SEC Form 3/4/5 filings; net = open-market P/S only
ETF ownership Held by 12 ETFs
Weight reflects direct equity holdings (N-PORT) only; leveraged or derivative-based funds may hold additional swap exposure not shown.
| Fund | Weight | Units | As of | Source |
|---|---|---|---|---|
| QQQS · Invesco Exchange-Traded Fund Trust … | 0.37% | 26,146 SH | Oct. 2, 2026 | Daily |
| IWC · iShares Trust | 0.03% | 116,144 SH | Sept. 11, 2026 | Daily |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0.01% | 196,817 SH | Aug. 19, 2026 | Daily |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0.01% | 25,268 SH | Aug. 19, 2026 | Daily |
| IWO · iShares Trust | 0.01% | 220,170 SH | Sept. 11, 2026 | Daily |
| RSSL · Global X Funds | 0.00% | 16,244 NS | July 31, 2026 | N-PORT |
| IWM · iShares Trust | 0.00% | 639,545 SH | Sept. 11, 2026 | Daily |
| VXF · VANGUARD INDEX FUNDS | 0.00% | 532,084 SH | Aug. 19, 2026 | Daily |
| VTI · VANGUARD INDEX FUNDS | 0.00% | 1,319,143 SH | Aug. 19, 2026 | Daily |
| VTWV · VANGUARD SCOTTSDALE FUNDS | 0.00% | 9,213 SH | Aug. 19, 2026 | Daily |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0.00% | 3,456 SH | Aug. 19, 2026 | Daily |
| IWN · iShares Trust | · | 92,189 SH | Sept. 11, 2026 | Daily |
NERV Analyst Consensus Bullish and bearish analyst opinions, 12-month price target, upside
rating · 9 analysts
BUY
Median target
$10.00
+204.9%
3 33.3%
Strong Buy
4 44.4%
Buy
2 22.2%
Hold
0 0.0%
Sell
0 0.0%
Strong Sell
12-Month Price Target
3 analysts · 2026-09-30Mean target $10.33 +215.0%
← Below all targets
Current price $3.28
Low$7.00
Mean$10.33
High$14.00
Peer comparison (GICS sub-industry) Key metrics vs sector peers
FY basis, prices as of each company's last fiscal year-end close.
| Ticker | Market Cap | P/E | Rev YoY | Net Margin | ROE | Gross Margin |
|---|---|---|---|---|---|---|
| NERV | $174M | -0.1 | · | · | 339.5% | · |
| ORGO | $658M | 34.5 | 17.0% | 6.6% | 13.9% | · |
| AVXL | · | -16.5 | -36.1% | -991.4% | · | · |
| VYGR | $232M | -1.9 | -49.5% | -296.5% | -54.4% | · |
| TARA | $286M | -4.0 | · | · | -33.7% | · |
| PEPG | $448M | -3.1 | · | · | -82.0% | · |
| CMPX | $958M | · | · | · | -45.9% | · |
| NBP | $1.06B | -19.0 | · | · | -21.4% | · |
| TNXP | $200M | -1.1 | 29.8% | -946.2% | -60.0% | · |
| ABOS | $128M | -1.1 | · | · | -129.4% | · |
| HUMA | · | · | · | · | · | · |
My Metrics Your personal watchlist — selected rows from Full Fundamentals
Pick the metrics that matter to you — click the + next to any row in Full Fundamentals above.
Your selection is saved and follows you across all tickers.
Source: SEC 10-Q filed Aug 7, 2026